Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab | BeOne Medicines

Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab

Beigene Study ID

BGB-A317-3111-10188-101

ClinicalTrials.gov ID

NCT04282018

China Drug Trials ID

CTR20220463

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

Accepts Healthy Volunteers? yes

No Study Documents